Tuesday, August 25, 2020 9:45:52 AM
Recent MRUS News
- Merus Announces Abstract Accepted for Presentation at the ESMO Asia Congress 2024 • GlobeNewswire Inc. • 09/17/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:03:03 PM
- Merus to Present at Canaccord Genuity’s 44th Annual Growth Conference • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update • GlobeNewswire Inc. • 08/01/2024 08:10:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:05:29 PM
- Merus Announces First Patient Dosed in LiGeR-HN2, a Phase 3 Trial Evaluating Petosemtamab in 2/3L r/m HNSCC • GlobeNewswire Inc. • 07/24/2024 11:00:00 AM
- Merus Announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 2L CRC • GlobeNewswire Inc. • 07/08/2024 12:00:00 PM
- Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2024 07:37:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 09:02:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:05:10 PM
- Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting • GlobeNewswire Inc. • 06/03/2024 06:30:00 PM
- Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting • GlobeNewswire Inc. • 06/02/2024 04:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/30/2024 09:21:57 PM
- Merus Announces Pricing of Upsized Public Offering of Common Shares • GlobeNewswire Inc. • 05/30/2024 01:30:00 AM
- Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/28/2024 08:29:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:06:03 PM
- Merus N.V. Announces Proposed Public Offering of Common Shares • GlobeNewswire Inc. • 05/28/2024 08:01:00 PM
- Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCC • GlobeNewswire Inc. • 05/28/2024 11:00:00 AM
- Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:00:00 PM
- Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/10/2024 08:33:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 08:35:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 08:30:45 PM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM